Telix Pharmaceuticals Limited American Depositary Shares (TLX)
NASDAQ
Closed
Oct 8, 2026
Day's Range
10.9352 wk Range
6.28Overview - TLX - Telix Pharmaceuticals Limited American Depositary Shares
Key Statistics
Valuation
Enterprise Value
4.21B
P/E (Trailing)
‪114.50‬
P/E (Forward)
‪-428.30‬
PEG Ratio
‪-428.30‬
Price / Sales (TTM)
‪4.35‬
Price / Book
‪9.33‬
EV / EBITDA
‪60.43‬
Profitability
Profit Margin
‪3.76%‬
Operating Margin
‪9.71%‬
Return on Assets
‪2.70%‬
Return on Equity
‪7.36%‬
Ownership
Shares Outstanding
338.77M
Float
273.60M
Short % of Shares Outstanding
‪0.11%‬
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.97%‬
Price stats
Beta
‪0.60‬
50-Day Avg
‪11.32‬
200-Day Avg
‪9.61‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
5 analysts
Average price target
‪$ 20.93‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - TLX - Telix Pharmaceuticals Limited American Depositary Shares
Peers - TLX - Telix Pharmaceuticals Limited American Depositary Shares
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
Profile Summary - TLX - Telix Pharmaceuticals Limited American Depositary Shares
About
Telix Pharmaceuticals Limited American Depositary Shares is a depositary share security representing ordinary shares of Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company focused on therapeutic and diagnostic radiopharmaceuticals. The company develops and commercializes products across…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
